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Discussion
About half of all men 50 years and older in the Tomor-
row Project had received one or more PSA tests in their
lifetime. This prevalence is consistent with data collec-
ted in 2001 from national databases, which indicated
that the average proportion of men who had received
one or more PSA tests in their lifetime was 43% among
those 40 years or age or older
10 and 47.5% among those
over the age of 50.
19 This was a substantial increase
from the 9% who, in
1995, reported hav-
ing had had a PSA
test in their lifetime,
in a Canada-wide
cross-sectional tele-
phone survey of 662
men over 40 years of
age.
25 The proportion
of men receiving PSA
tests has also been in-
creasing systematic-
ally over the last
decade in the United
States, and recent
PSA test rates are re-
ported to be greater
than 40% for men
over 40 attending
regular health care fa-
cilities.
15,22
Clinical indica-
tions for ordering a
PSA test can include
lower urinary tract
symptoms (symp-
toms of prostatism),
history of benign pro-
state hyperplasia, a
recent abnormal
DRE, and a history of
first-degree relatives
diagnosed with pro-
state cancer. Some
surveys conducted
within clinical set-
tings have observed
that PSA testing rates
are much higher
among men with be-
nign prostatic hyper-
plasia or moderate or
severe urinary tract
symptoms compared
with asymptomatic
men.
17 McGregor and
colleagues16 also ob-
served that the majority of men in a 1996 population-
based Alberta survey who had received a PSA test had a
clinical indication for the test. This group represented
those men at a possibly higher risk for prostate cancer
and who were eligible for a PSA test under the Alberta
provincial health insurance reimbursement plan. Con-
versely, the majority of the PSA tests in the Alberta To-
morrow cohort were in asymptomatic men (58%),
suggesting a possible shift toward opportunistic screen-
ing in clinical practice.Research Richardson et al
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In our study population we observed that the PSA
screening rates differed significantly by household in-
come. Higher income was not identified as a predictor
of PSA testing in a number of cross-sectional studies
conducted in the United States,
15,26 but was associated
with PSA testing in a cohort of American veterans who
were interviewed on two separate occasions in 1992
and 1995.
14 Interestingly, all these studies observed a
positive association between access to health insurance
and PSA testing.
14,15,26 Although access to health care in-
surance is an important determinant of screening in
the United States,
18,22,27 this is not the case in Canada,
given our universal health care coverage. However,
measuring access to care by socioeconomic status can
be important to help determine if provincial health care
systems are delivering access to services in an equitable
manner. At least two Canadian surveys have observed
that high-income earners are more likely to have a fam-
ily physician,
28,29 and regular visits with a family doctor
appears to influence PSA testing rates.
19,30 Interest-
ingly, the men in this cohort study who had ever under-
gone screening for colon cancer with a fecal occult
blood test were significantly more likely to have a PSA
test despite an absence of symptoms, and the frequency
fecal occult blood testing also appeared to increase
with increasing income (data not shown). Therefore, it
is possible that, in our cohort, a higher income is re-
lated to increased health care access or an increased
awareness of the availability of PSA testing and other
cancer screening options by patient or health care pro-
vider.
An increase in physician awareness of PSA testing
may also explain part of the increased prevalence of
testing. Among men with family physicians, the use of
PSA testing varies depending on the insistence of the
patient and on the physician’s views on the wisdom of
using PSA tests for early detection of prostate can-
cer.
11,12,31 According to a study in Ontario, family physi-